In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...

LSCD is a debilitating eye condition where the cornea loses the adult stem cells responsible for repair and regeneration.

Two years after surgery, three patients experienced improved corneal transparency with no serious side effects.

Yamaha Motor Co., Ltd. (Tokyo: 7272) announced today the upcoming release of the new CELL HANDLER (TM) 2, a cell picking and ...

In a global first, a groundbreaking stem cell transplant has successfully restored the vision of three people with severe corneal damage. The clinical trial, which was conducted in Japan, marks a ...

Fate Therapeutics Inc ( (FATE) ) has released its Q3 earnings. Here is a breakdown of the information Fate Therapeutics Inc presented to its ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...